Financials

  • Market Capitalization 6.1 M
  • Employee 2
  • Founded 2003
  • CEO N/A
  • Website www.pulmatrix.com
  • Headquarter Delaware, United States
  • FIGI BBG003TH2QL1
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.58
Relación precio/flujo de caja

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4928
XTLB
XTL Biopharmaceuticals Ltd - American Depositary Shares
2.81 USD-2.43%-4.42%+21.65%+212.92%6.65 M USD
4935
CURX
Curanex Pharmaceuticals Inc - Common Stock
0.22 USD+4.76%-4.35%-31.25%-94.21%6.24 M USD
4945
ADIL
Adial Pharmaceuticals, Inc - Common Stock
2.75 USD-2.83%-5.50%-11.86%+663.89%5.89 M USD
4953
MLEC
Moolec Science SA - Ordinary Shares
7.16 USD-9.14%-5.17%-3.89%+87.43%5.20 M USD

Noticias